BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1799 related articles for article (PubMed ID: 12365904)

  • 1. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.
    Heijl A; Leske MC; Bengtsson B; Hyman L; Bengtsson B; Hussein M;
    Arch Ophthalmol; 2002 Oct; 120(10):1268-79. PubMed ID: 12365904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Manifest Glaucoma Trial: design and baseline data.
    Leske MC; Heijl A; Hyman L; Bengtsson B
    Ophthalmology; 1999 Nov; 106(11):2144-53. PubMed ID: 10571351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.
    Leske MC; Heijl A; Hussein M; Bengtsson B; Hyman L; Komaroff E;
    Arch Ophthalmol; 2003 Jan; 121(1):48-56. PubMed ID: 12523884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of long-term progression in the early manifest glaucoma trial.
    Leske MC; Heijl A; Hyman L; Bengtsson B; Dong L; Yang Z;
    Ophthalmology; 2007 Nov; 114(11):1965-72. PubMed ID: 17628686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disc hemorrhages and treatment in the early manifest glaucoma trial.
    Bengtsson B; Leske MC; Yang Z; Heijl A;
    Ophthalmology; 2008 Nov; 115(11):2044-8. PubMed ID: 18692244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
    Bengtsson B; Leske MC; Hyman L; Heijl A;
    Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial.
    Heijl A; Leske MC; Hyman L; Yang Z; Bengtsson B;
    Acta Ophthalmol; 2011 Dec; 89(8):749-54. PubMed ID: 20236252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of argon laser trabeculoplasty in the Early Manifest Glaucoma Trial.
    Heijl A; Peters D; Leske MC; Bengtsson B
    Am J Ophthalmol; 2011 Nov; 152(5):842-8. PubMed ID: 21843876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and vision-related quality of life in the early manifest glaucoma trial.
    Hyman LG; Komaroff E; Heijl A; Bengtsson B; Leske MC;
    Ophthalmology; 2005 Sep; 112(9):1505-13. PubMed ID: 16019074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and Functional Progression in the Early Manifest Glaucoma Trial.
    Öhnell H; Heijl A; Brenner L; Anderson H; Bengtsson B
    Ophthalmology; 2016 Jun; 123(6):1173-80. PubMed ID: 26949119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
    Krupin T; Liebmann JM; Greenfield DS; Rosenberg LF; Ritch R; Yang JW;
    Ophthalmology; 2005 Mar; 112(3):376-85. PubMed ID: 15745762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of intraocular pressure in the early manifest glaucoma trial: A 6-year follow-up.
    Hyman L; Heijl A; Leske MC; Bengtsson B; Yang Z;
    Arch Ophthalmol; 2010 May; 128(5):601-7. PubMed ID: 20457982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The United Kingdom Glaucoma Treatment Study: a multicenter, randomized, double-masked, placebo-controlled trial: baseline characteristics.
    Lascaratos G; Garway-Heath DF; Burton R; Bunce C; Xing W; Crabb DP; Russell RA; Shah A;
    Ophthalmology; 2013 Dec; 120(12):2540-2545. PubMed ID: 24126032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study.
    Lindén C; Heijl A; Jóhannesson G; Aspberg J; Andersson Geimer S; Bengtsson B
    Acta Ophthalmol; 2018 Sep; 96(6):567-572. PubMed ID: 30242986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J; Coleman AL
    Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial.
    Leske MC; Heijl A; Hyman L; Bengtsson B; Komaroff E
    Curr Opin Ophthalmol; 2004 Apr; 15(2):102-6. PubMed ID: 15021220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of open-angle glaucoma.
    Heijl A; Bengtsson B; Hyman L; Leske MC;
    Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optic disc and visual field changes after trabeculectomy.
    Kotecha A; Spratt A; Bunce C; Garway-Heath DF; Khaw PT; Viswanathan A;
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4693-9. PubMed ID: 19474409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of glaucoma progression by perimetry and optic disc photography at different stages of the disease: results from the Early Manifest Glaucoma Trial.
    Öhnell H; Heijl A; Anderson H; Bengtsson B
    Acta Ophthalmol; 2017 May; 95(3):281-287. PubMed ID: 27778463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma.
    Watson PG; Barnett MF; Parker V; Haybittle J
    Br J Ophthalmol; 2001 Aug; 85(8):962-8. PubMed ID: 11466256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 90.